Exact Mass: 456.3025644

Exact Mass Matches: 456.3025644

Found 20 metabolites which its exact mass value is equals to given mass value 456.3025644, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Docosahexaenoyl Glutamine

4-(C-Hydroxycarbonimidoyl)-2-[(1-hydroxydocosa-4,7,10,13,16,19-hexaen-1-ylidene)amino]butanoate

C27H40N2O4 (456.29879200000005)


N-docosahexaenoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Glutamine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

13Z-Labdene-8alpha,15,16-triol 8-beta-L-xylopyranoside

13Z-Labdene-8alpha,15,16-triol 8-beta-L-xylopyranoside

C25H44O7 (456.3086874)


   

15-hydroxy-13-epi-manoyl oxide-14-O-alpha-L-arabinopyranoside|tarapacol-14-O-alpha-L-arabinopyranoside

15-hydroxy-13-epi-manoyl oxide-14-O-alpha-L-arabinopyranoside|tarapacol-14-O-alpha-L-arabinopyranoside

C25H44O7 (456.3086874)


   
   

24,24-Difluoro-1,25,26-trihydroxyvitamin D3

(7E)-(1R,3R)-24,24-difluoro-19-nor-9,10-seco-5,7-cholestadiene-1,3,25,26-tetrol

C26H42F2O4 (456.3050996)


   

N-docosahexaenoyl glutamine

N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-glutamine

C27H40N2O4 (456.29879200000005)


   

Bis(11-azidoundecyl) disulfide

Bis(11-azidoundecyl) disulfide

C22H44N6S2 (456.3068704)


   

aluminum,2-ethylhexanoate

aluminum,2-ethylhexanoate

C24H45AlO6 (456.303138)


   

1,3,5-Tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene

1,3,5-Tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene

C24H39B3O6 (456.3025644)


   

2-[4-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]butyl]guanidine

2-[4-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]butyl]guanidine

C26H40N4O3 (456.310025)


   

[(1S,2R,3S,4S,5R)-5-azaniumyl-2-[(2R,3R,6S)-3-azaniumyl-6-(azaniumylmethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5S,6R)-4-azaniumyl-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]azanium

[(1S,2R,3S,4S,5R)-5-azaniumyl-2-[(2R,3R,6S)-3-azaniumyl-6-(azaniumylmethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5S,6R)-4-azaniumyl-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]azanium

C18H42N5O8+5 (456.3033232)


   

5-amino-2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-5-oxopentanoic acid

5-amino-2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-5-oxopentanoic acid

C27H40N2O4 (456.29879200000005)


   

N-[(2R,3R,4aS,6S,8aS)-2-[2-[4-(1-cyclohexenyl)phenyl]ethyl]-6-(hydroxymethyl)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-3-yl]-2-(dimethylamino)acetamide

N-[(2R,3R,4aS,6S,8aS)-2-[2-[4-(1-cyclohexenyl)phenyl]ethyl]-6-(hydroxymethyl)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-3-yl]-2-(dimethylamino)acetamide

C27H40N2O4 (456.29879200000005)


   

1-({(1s,4s,6s)-6-Isopropyl-3-methyl-4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-2-cyclohexen-1-yl}methyl)-3-(3-methoxyphenyl)urea

1-({(1s,4s,6s)-6-Isopropyl-3-methyl-4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-2-cyclohexen-1-yl}methyl)-3-(3-methoxyphenyl)urea

C26H40N4O3 (456.310025)


   
   
   

(2s,3r,4s,5s)-2-{1-[(3s,4ar,6as,10as,10br)-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy}oxane-3,4,5-triol

(2s,3r,4s,5s)-2-{1-[(3s,4ar,6as,10as,10br)-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy}oxane-3,4,5-triol

C25H44O7 (456.3086874)


   

2-(1-{3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl}-2-hydroxyethoxy)oxane-3,4,5-triol

2-(1-{3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl}-2-hydroxyethoxy)oxane-3,4,5-triol

C25H44O7 (456.3086874)


   

(2r,3s,4r,5s)-2-{[(1r,2r,4as,8as)-1-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-2-yl]oxy}oxane-3,4,5-triol

(2r,3s,4r,5s)-2-{[(1r,2r,4as,8as)-1-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-2-yl]oxy}oxane-3,4,5-triol

C25H44O7 (456.3086874)


   

2-({1-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-2-yl}oxy)oxane-3,4,5-triol

2-({1-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-2-yl}oxy)oxane-3,4,5-triol

C25H44O7 (456.3086874)